Paper42657492
HMGB1 as a danger signal in vascular remodeling.
Kim JY and 4 others. Korean J Physiol Pharmacol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. HMGB1 as a danger signal in vascular remodeling. Papers, record 42657492. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42657492
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References206
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18431461 | HMGB1: endogenous danger signaling. | Mol Med | 2008 | https://conductscience.org/library/papers/18431461 | PubMed |
| 2 | 28699690 | microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. | J Cell Mol Med | 2017 | https://conductscience.org/library/papers/28699690 | PubMed |
| 3 | 10391939 | Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10391939 | PubMed |
| 4 | 37815057 | Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis. | J Am Heart Assoc | 2023 | https://conductscience.org/library/papers/37815057 | PubMed |
| 5 | 20123072 | HMGB proteins: interactions with DNA and chromatin. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20123072 | PubMed |
| 6 | 19064698 | Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. | J Exp Med | 2008 | https://conductscience.org/library/papers/19064698 | PubMed |
| 7 | 32265930 | Targeting Inflammation Driven by HMGB1. | Front Immunol | 2020 | https://conductscience.org/library/papers/32265930 | PubMed |
| 8 | 15699456 | Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. | Hypertension | 2005 | https://conductscience.org/library/papers/15699456 | PubMed |
| 9 | 38645427 | Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38645427 | PubMed |
| 10 | 14871459 | Amphoterin as an extracellular regulator of cell motility: from discovery to disease. | J Intern Med | 2004 | https://conductscience.org/library/papers/14871459 | PubMed |
| 11 | 31061925 | Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response. | JACC Basic Transl Sci | 2019 | https://conductscience.org/library/papers/31061925 | PubMed |
| 12 | 35940074 | α-Iso-cubebene attenuates neointima formation by inhibiting HMGB1-induced monocyte to macrophage differentiation via suppressing ROS production. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35940074 | PubMed |
| 13 | 29385543 | Smooth muscle cell fate and plasticity in atherosclerosis. | Cardiovasc Res | 2018 | https://conductscience.org/library/papers/29385543 | PubMed |
| 14 | 15731494 | Mechanisms, pathophysiology, and therapy of arterial stiffness. | Arterioscler Thromb Vasc Biol | 2005 | https://conductscience.org/library/papers/15731494 | PubMed |
| 15 | 39198225 | Biophysically stressed vascular smooth muscle cells express MCP-1 via a PDGFR-β-HMGB1 signaling pathway. | Korean J Physiol Pharmacol | 2024 | https://conductscience.org/library/papers/39198225 | PubMed |
| 16 | 25593275 | Inflammation and immunity in diseases of the arterial tree: players and layers. | Circ Res | 2015 | https://conductscience.org/library/papers/25593275 | PubMed |
| 17 | 17548579 | A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. | Blood | 2007 | https://conductscience.org/library/papers/17548579 | PubMed |
| 18 | 32246225 | New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. | Angiogenesis | 2020 | https://conductscience.org/library/papers/32246225 | PubMed |
| 19 | 35820641 | HMGB1 induced endothelial to mesenchymal transition in liver fibrosis: The key regulation of early growth response factor 1. | Biochim Biophys Acta Gen Subj | 2022 | https://conductscience.org/library/papers/35820641 | PubMed |
| 20 | 37559007 | Platelet-derived extracellular vesicles promote endothelial dysfunction in sepsis by enhancing neutrophil extracellular traps. | BMC Immunol | 2023 | https://conductscience.org/library/papers/37559007 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42657492
GET https://conductscience.org/api/papers/v1/42657492/references?page=2